The Ultrex and Ultrex Plus penile prosthesis incorporate sequential design modi®cations that afford important functional advantages that reduce the potential for mechanical failure. This retrospective study reviews our experience with these models emphasizing innovations in surgical technique and postoperative results.
Introduction
Prosthesis design and implantation technique have evolved steadily over recent years with a broader extension of this treatment option and a more favorable surgical outcome. Several variations of the multicomponent in¯atable penile prostheses have been available for surgical treatment since Scott et al, 1 introduced, the ®rst in¯atable penile prosthesis. Subsequently, the in¯atable penile prosthesis has undergone multiple design modi®cations in order to assure greater durability and improved function with the latest generation of this model consisting of the Ultrex and Ultrex Plus in¯atable penile prosthesis. The Ultrex cylinder design, introduced in 1990, includes inner and outer layers of silicone and a middle layer of woven Lycra and Dacron, which allows length extension and girth expansion up to 18 mm within the corpora cavernosa and, therefore, facilitates optimal sizing of the cylinders. In 1992, the AMS 700 Ultrex Plus was introduced incorporating preconnected tubing between the pump and the cylinders. Since their introduction, there has been relatively little reported on the mechanical reliability, surgical outcome, complications, and patient satisfaction with these models. We report herein a retrospective review of our surgical experience and outcome, and present innovative techniques that facilitate implantation of the reservoir and in¯ate/de¯ate device.
Materials and methods

Patient population
From May of 1990 to July of 1994, a total of 90 impotent males between the ages of 29 and 74 (mean age 56.8 y) underwent implantation with either the Ultrex (31%) or Ultrex Plus (69%) penile prosthesis. All patients were diagnosed with oragnic erectile dysfunction following comprehensive multidisciplinary evaluation that included history, physical examination, hormone pro®le, urinalysis, fasting blood sugar, penile brachial systolic index, and, when indicated, biothesiometry, nerve conduction studies, nocturnal penile tumescence study, pharmacocavernosometry and cavernosography. Vascular disease (42 patients) and diabetes mellitus (23 patients) accounted for the majority of organic etiologies ( Table 1) . The majority of patients received their implants during the 6th or 7th decade of life. Vascular disease proved to be the primary etiologic factor responsible for impotence in every decade of life except for the 5th decade, in which diabetes mellitus was primarily responsible. A total of eight patients (10%) underwent implantation of an Ultrex or Ultrex Plus following explant of an earlier model prosthesis because of malfunction (6) or patients' desire for conversion from a semi-rigid prosthesis to a multicomponent in¯atable prosthesis (2) . Only 18 patients were implanted with a multicomponent in¯atable penile prosthesis as their initial form of impotence treatment. The remaining 74 men underwent various non-surgical options prior to implantation. These consisted of oral medication, intracavernous therapy, vacuum erection device, penile venous ligation, intramuscular testosterone supplementation, and various combined nonsurgical options (Table 2) . Patients were followed after the early postoperative period on a quarterly basis for 1 y and semi-annually thereafter. Patients followed for a maximum interval of 50 months (range 7±50 months).
Operative technique
All implantation procedures were performed by the same surgeon at our institution. The skin was scrubbed thoroughly with povidone iodine for 10 min prior to incision and the Foley catheter was inserted using antibiotic lubricant. Prophylactic broad spectrum intravenous antibiotics consisting of gentamycin (80 mg) and vancomycin (1 mg) were administered perioperatively and local antibiotic solution consisting of bacitracin, polymixin and neosporin was instilled periodically into all compartments intraoperatively. Intravenous antibiotics were administered for a 24 h period after which oral cipro¯oxacin 500 mg was taken twice daily for 7± 10 d. Topical bacitracin ointment was placed on the incision(s) twice daily for at least three weeks. In all patients we utilized a single midline penoscrotal incision 2 through which all components are inserted. We applied the concept of radial dilatation 3 to all three compartments to accommodate the in¯ate/de¯ate device, in¯atable cylinders and reservoir. Following a 2 cm corporotomy, subtunical dissection is carried out using Metzenbaum scissors from the proximal corporal limit (ischial tuberosity) to the distal (midglandular) limit. The corporal bodies are then radially dilated with the dilamezinsert up to a diameter of 14 mm in a single nontraumatic step, thus avoiding the sheering forces of repeated longitudinal dilatation. The cylinders are then placed into the corporal bodies with rear tip extenders used as needed. With the Metzenbaum scissors, a dependently positioned dartos pouch is then developed in the inferior-most portion of the scrotum. Consistent with the concept of radial dilatation, a 4 in nasal speculum is inserted and spread open, thus creating a spacious compartment for the in¯ate/de¯ate device. The tubing is then routed through the tunica vaginalis and the dartos pouch is closed in the usual manner. The preconnected tubing between the in¯ate/de¯ate device and the cylinders may be buried deeper in the scrotum by incising the posterior leaf of the dartos pouch and the closing the walls of this lea¯et over the tubing during the dartos closure. This technique internalizes the tubing within the scrotum, avoiding potential pressure necrosis on the scrotal skin. The corporotomies are closed and the surrogate reservoir We have recently developed a unique method for reservoir insertion consisting of nontraumatic radial dilatation of the prevesical space. This avoids a separate inguinal incision and closure and minimizes the potential for bladder and blood vessel injury. 4 Through the original penoscrotal incision, blunt and sharp dissection is carried superiorly over the pubic tubercle medial to the level of the external inguinal ring. The transversalis and endopelvic fascia are perforated allowing entry to the prevesical space. The trocar mounted laparoscopic preperitoneal distension balloon (Origin Medsystems, Inc., Menlo Park, CA) is then easily and non-traumatically inserted into the prevesical space and insufated with 150±200 cc of air; the in¯ated balloon remains in situ for approximately 3 min. This volume is more than adequate to create a space accommodating either a 65 ml or 100 ml reservoir. The preperitoneal distension balloon (PDB) is de¯ated and the device removed, followed by palpation to con®rm the adequacy of the space. The compartment is irrigated with antibiotic solution and the reservoir is easily inserted and in¯ated with the proper volume of normal saline. Closure of the small fascial defect is not required. At this point, the back pressure re®ll test is performed to insure full expansion of the reservoir's compartment. Finally, the reservoir is connected to the in¯ate/ de¯ate device using the Quik-connect system (American Medical Systems, Minnetonka, MN). At the completion of the procedure, the entire system is tested and the cylinders are left partially in¯ated for corporal tamponade.
Results
Twenty-weight men received the AMS 700 Ultrex model while 62 were implanted with the Ultrex Plus. During a maximum follow-up interval of 50 months (range 7±50 months) we observed an 8% complication rate and no mechanical failure. On all follow-up visits, patients are critically questioned regarding their overall satisfaction with functional anatomic, and cosmetic issues, ease of operation as well as frequency of use of their device. Long-term satisfaction was noted in these areas in 95% of patients. Partners were not surveyed.
A total of three intraoperative and postoperative complications have occurred in our series. A small bladder perforation occurred while bluntly dissecting out the prevesical space (prior to the availability of the PDB) in a patient with previous radical retropubic prostatectomy. The injury was repaired primarily with completion of the implantation procedure. Postoperatively, a cystogram failed to show extravasation after one week of catheter drainage. Two additional complications occurred, one in a paraplegic and the other in a diabetic who developed a scrotal erosion of the in¯ate/de¯ate device two months after implantation of the Ultrex Plus. Based on the literature's experience in the setting of prosthetic infection, explant of the Ultrex Plus and simultaneous salvage with a Dyna¯ex prosthesis was performed with satisfactory outcome in both men. 5, 6 From a technical standpoint, we have experienced no mechanical failures, such as aneurysmal bulging, auto-in¯ation, system leakage, or spontaneous de¯ation. Two patients in our series have reported dissatisfaction with their prostheses despite completely normal function of the device. Three men reported corporal deformity with deviation of the penile shaft upon in¯ation. In one, this complication was adequately addressed by replant with 700 CX cylinders. An additional patient noted transient penile hyperesthesia associated with a slight degree of discomfort, over the course of several months of follow-up.
Discussion
Since its inception, the multicomponent in¯atable penile prosthesis has undergone sequential design and construction modi®cations that have afforded important functional advantages and have greatly reduced the potential for mechanical failure. These advances include the incorporation of Dacronreinforced cylinders, te¯on-coated exit tubing, kink-free tubing, and force ®t tubing connectors. Prior to these modi®cations malfunctions such as, aneurysmal dilatation and tubing leaks were noted in 5±10% of patients over a 20 month follow-up interval. 7 The AMS 700 Ultrex cylinder was introduced to provide a more natural prosthetic erection by expansion of the cylinder, both in girth and length. The Ultrex cylinder consists of a bi-directionally woven Dacron and Lycra layer situated between an inner and outer layer of silicone. Expansion in girth from 12 mm to 18 mm is thus made possible, while still resisting aneurysmal bulge. Longitudinal extension of the Ultrex cylinder up to as much as 20% is also facilitated by this design. 8 This feature allows the cylinder to adapt to changes in corporal length over time. The importance of the Ultrex cylinder's ability to expand longitudinally is supported by the fact that the implanted corpus cavernosum expands with time, extending, on average, a length of 1.67 cm in re-operated patients. 9 Importantly, the advantage of longitudinal extension simpli®es intraoperative sizing since these cylinders will ®ll fractional corporal measurements by allowing the implanting surgeon to select a slightly undersized (0.5 cm less) cylinder without consequence.
Despite the apparent advantage of longitudinal expansion, sizing of Ultrex cylinders should be done cautiously. Wilson et al 10 recently reported development of an S-shaped corporal deformity in 32% of patients undergoing Ultrex prosthesis implantation. They attributed this development to a number of risks factors including prolonged cylinder in¯ation, previous implant surgery, and the presence of Peyronie's disease. This group recommended intentional down sizing of Ultrex cylinders at the time of implantation, advising patients to avoid prolonged in¯ation of the Ultrex cylinders. In the setting of Peyronie's disease and previous semi-rigid implant, the AMS 700 CX or Mentor Alpha prosthesis should be used to reduce the risk of corporal deformity. If phalloplasty is performed in conjunction with the latter model one should avoid the use of electrocautery to incise the tunica since this can damage the underlying bio¯ex cylinders of the Mentor Alpha prosthesis. Indeed, corporal deformity was noted in our series in 3 of the 90 patients and was recti®ed by re-implantation with controlled expansion cylinders.
The overall incidence of penile prosthesis infection ranges from 1±4% with Staph epidermidis being the most common infecting organism. Surgical aseptic technique, perioperative antibiotics, intraoperative skin preparation and antibiotic irrigation have had a fundamental role in achieving these low rates of infection. A number of studies 11±13 have attempted to determine risk factors associated with infection of penile prostheses. They found that conditions which predisposed patients to urinary tract infections (namely diabetes mellitus, spinal cord injury, neurogenic bladder and ileal conduit) placed patients at a higher risk for prosthetic infections. Carson and Robertson 14 reported six infected penile implants, two of which had urinary tract infections with gram negative organisms, which were also cultured from the infected device. Additional reports seem to verify this association. Merrill 15 reported six prosthetic infections of 301 implants, two of which occurred in patients with a neurogenic bladder for an infection rate of 12.5% in patients with neurogenic bladder. Kabalin Infection of the penile prosthesis, although uncommon, remains one of the most serious complications of implantation and often results in signi®cant patient morbidity and loss of the device. The assumption is that infection is the cause of the subsequent erosion and will inevitably spread to other components of the device. Unfortunately, explant alone may result in extensive ®brosis in the corporal compartments, making future re-implantation dif®cult. Furlow and Goldwasser 4 questioned whether all erosions were the result of infection and advocated simultaneous device salvage in cases of erosion. The use of drains and postoperative antibiotic irrigation was felt to enhance the success of this approach. In our series, a paraplegic and a diabetic developed a scrotal erosion after implantation of the Ultrex Plus device. Following three days of preoperative intravenous antibiotics, they both underwent explant of their Ultrex prosthesis followed by simultaneous salvage with a self-contained in¯atable (Dyna¯ex) prosthesis. No drains or postoperative antibiotic irrigation were used. Review of their course 28 and 32 months after these salvage procedures, neither patient has experienced any further complications.
To simplify the procedure of multicomponent prosthesis implantation we have incorporated the technique of controlled radial dilatation for creation of the scrotal, corporal and prevesical compartments which house the individual components of the Ultrex Plus penile prosthesis. This involves a single dilatation step which is less traumatic, saves time, and offers various functional and cosmetic advantages postoperatively. Speci®cally, uniform radial dilatation of the corpora cavernosa is achieved in a single non-traumatic step using the dilamezinsert. This obviates the sequential passage of Hegar or Mentor dilators, which utilize tangential dilatation resulting in longitudinal sheering forces that may cause postoperative in¯ammation and edema of the penile shaft. Alternatively, the dilamezinsert with radial distention is especially suitable for dilating ®brotic corpora cavernosa secondary to priapism, prior intracorporal injection therapy, infection or previous explanation. Radial dilatation of the scrotal pouch using a long nasal speculum results in minimal bleeding with less scrotal hematoma and edema postoperatively. In addition, a maximally dependent scrotal position is assured. The Preperitoneal Distention Balloon (PDB) creates a radially dilated space of adequate volume to avoid back pressure on the reservoir. This single step of controlled distention may be performed through the penoscrotal incision and minimizes potential bladder and blood vessel injury, often caused by blunt sweeping dissection, especially in the setting of pelvic ®brosis secondary to previous surgery or Ultrex and ultrex plus in¯atable penile prosthesis SN Liberman et al radiation. In patients with previous intraperitoneal exposure, however, the PDB should be deployed only after assuring freedom from intraperitoneal adhesion to the pubis. In the present series, radial balloon distention was performed in the last 32 consecutive patients with the potential advantages of minimized autoin¯ation, a less traumatic prevesical dissection, shortened operative time and less early postoperative morbidity. Eight of these 32 patients had previously undergone radical pelvic surgery bene®ted from this technique of prevesical space creation (6 radial prostatectomies, 1 cystectomy and diversion, and 1 ileal neobladder.) In addition, the incidence of post operative functional complications such as autoin¯ation, which usually results from a restrictive ®brous sheath encroaching upon the reservoir may be lowered. Furthermore, this technique should allow for the increased use of multicomponent models over self contained devices in patients with prior inguinal or pelvic surgery, thus providing them with the functional and cosmetic advantages of the multicomponent device.
